Category: Insights - Page 33 - DrugPatentWatch

A simplified, schematic overview of stakeholders and relationships in the pharmaceutical market. Own work.

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks

This paper was originally published by Toon van der Gronde, Carin A. Uyl-de Groot, and Toine Pieters in PLoS ONE 12(8): e0182613 […]

Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks Read Post »

What Happens When a Drug Patent Expires? Drug Patent Life

When a drug patent expires, it sets off a chain of events that significantly impacts the pharmaceutical market, drug prices,

What Happens When a Drug Patent Expires? Drug Patent Life Read Post »

Figure 1 USFDA registrations of ARVs for PEPFAR

Insights

The US Food and Drug Administration’s tentative approval process and the global fight against HIV

This paper was originally published by Harinder Singh Chahal, Jeffrey S Murray, Martin Shimer, Peter Capella, Ryan Presto, Mary Lou Valdez,

The US Food and Drug Administration’s tentative approval process and the global fight against HIV Read Post »

Table 1. Non-dilutive funding opportunities for drug repurposing initiatives.

Insights

Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics

This paper was originally published by J. Javier Hernandez, Michael Pryszlak, Lindsay Smith, Connor Yanchus, Naheed Kurji, Vijay M. Shahani and

Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics Read Post »

Insights, Tips, Tricks, and Case Studies

Improve Your Litigation Success, Predict Settlement Terms, and Write Better Patents by Analyzing Patent Challenges

Litigation related to drug patents, whether it be direct patent challenges, contract disputes, or other cases, can provide direct intelligence

Improve Your Litigation Success, Predict Settlement Terms, and Write Better Patents by Analyzing Patent Challenges Read Post »

Featured, Insights, Tips, Tricks, and Case Studies

Gain Intelligence on Royalties, Settlements, and More with Drug Patent Litigation Information

Disclosure: the majority of the companies mentioned below are, or have been, clients of DrugPatentWatch Drug patent litigation can be

Gain Intelligence on Royalties, Settlements, and More with Drug Patent Litigation Information Read Post »

Insights

How Pharmacists Are Trapped in the Middle of Drug Price Wars

Pharmacists find themselves caught in a precarious position, sandwiched between the escalating costs of prescription drugs and the increasing demands

How Pharmacists Are Trapped in the Middle of Drug Price Wars Read Post »

Featured, Insights, Tips, Tricks, and Case Studies

How to Use Tentative Drug Approvals to Anticipate Generic Entry

One powerful tool that savvy industry professionals use to gain a competitive edge is the analysis of tentative drug approvals.

How to Use Tentative Drug Approvals to Anticipate Generic Entry Read Post »

Figure 1 - Study design for substitution analyses

Guest Content, Insights

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study

This paper was originally published by Rishi J Desai, Ameet Sarpatwari, Sara Dejene, Nazleen F Khan, Joyce Lii, James R Rogers, Sarah K Dutcher, Saeid Raofi, Justin Bohn,

Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study Read Post »